COO
The Cooper Companies, Inc.
September 9, 2026 · pre-market
- Rarity
- 2.28
- Peak move
- −7.39%
- Float cap
- $13.2B
The Cooper Companies is a global medical device company selling in over 130 countries through two segments. CooperVision manufactures contact lenses and myopia management products, including the MiSight 1 day lens. CooperSurgical provides fertility and women's health products and services to healthcare professionals and fertility clinics.
Where do you see this going?
no votes yetVoting closed at 4:00 PM ET.
What we found
3 events · 0 from SEC or newswire · 0 timed with the moveanalyst_ratingCitigroup analyst Joanne Wuensch maintained a Neutral rating on The Cooper Companies (COO) and raised the price target to $80 from $76.
product_launchCooperVision launched its clariti 1 day multifocal contact lens in Italy on September 9, 2026.
institutional_flowNykredit A/S disclosed acquiring a new stake of 28,865 shares in The Cooper Companies (COO) in its second-quarter 2026 SEC filing.